The strategic importance of mRNA vaccine technologies in Africa for achieving public health independence
16 July 2026
To build mRNA vaccine manufacturing capacity in Africa, significant progress has been made in developing human, technical, and regulatory capacity.
Here we highlight these developments and summarise hurdles that need to be overcome before a self-sustaining mRNA vaccine production ecosystem is established on the continent. Read our latest article in Nature Communications.
